0001567619-19-011205.txt : 20190515 0001567619-19-011205.hdr.sgml : 20190515 20190515161402 ACCESSION NUMBER: 0001567619-19-011205 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190515 DATE AS OF CHANGE: 20190515 EFFECTIVENESS DATE: 20190515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Athyrium Capital Management, LP CENTRAL INDEX KEY: 0001728001 IRS NUMBER: 263965190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18509 FILM NUMBER: 19828280 BUSINESS ADDRESS: STREET 1: 505 FIFTH AVENUE, FLOOR 18 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-402-6925 MAIL ADDRESS: STREET 1: 505 FIFTH AVENUE, FLOOR 18 CITY: NEW YORK STATE: NY ZIP: 10017 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001728001 XXXXXXXX 03-31-2019 03-31-2019 Athyrium Capital Management, LP

505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017

13F HOLDINGS REPORT 028-18509 N Andrew Hyman 212-402-6925 /s/ Andrew Hyman New York NY 05-15-2019 0 2 97853 false INFORMATION TABLE 2 form13fInfoTable.xml AEGERION PHARMACEUTICALS INC NOTE 2.000% 8/1 00767EAB8 86826 117737000 PRN SOLE 0 0 117737000 KALA PHARMACEUTICALS INC COM 483119103 11027 1333333 SH SOLE 1333333 0 0